What happened?
EMA’s September committee meeting recommended VaxRabeo, an inactivated rabies vaccine, for pre-exposure and post-exposure prophylaxis.
Why does it matter?
The recommendation concerns prevention of a serious infection.
How to interpret the evidence
This is a committee recommendation, with the European Commission authorisation process still to follow.
What remains uncertain?
It does not confirm availability in Malta or replace individual advice about exposure.
Medical News provides general health education. Individual treatment decisions depend on your circumstances and the advice of your clinical team.